MiMedx Group, Inc.

MDXG·NasdaqCM
Compare
3.2000−0.0500 (−1.54%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close3.2500
Open3.3100
Day range3.15003.4400
52-week range3.03007.9700
Off day high−6.98%
Off 52-week high−59.85%
Volume1.76M
Avg. volume (3M)1.30M
Market cap466.96M
EPS (TTM)-0.1300
Forward P/E30.00
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding145.93M
Short interest—
Earnings dateOct 28, 2026
Analyst target—
Profit margin—

Against its peers

Compare in full ›
MDXG BSEM MDWD CELU CNXU ICCC
Market cap 466.96M 21.47M 183.33M 26.25M 68.45M 94.18M
P/E (TTM) — 1.3 — — — 148.1
Forward P/E 30.0 4.0 -6.2 -1.4 -4.2 -94.3
Price/book 2.2 0.7 5.1 -0.7 10.4 3.0
Dividend yield — — — — — —
1-year change −59.17% −71.95% −26.23% −55.60% −81.79% +62.70%
Today −1.54% 0.00% +6.05% −1.02% −6.72% +1.17%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All MDXG news ›
Seeking Alpha·Positive

MIMEDX announces $25M patent license agreement

MiMedx settles patent dispute with a wound care rival in a $25M licensing deal. - MiMedx Group (MDXG) on Wednesday said it has entered into a license agreement with a wound care competitor that resolves allegations of infringement of…

Markets Daily·

MiMedx Group (MDXG) Set to Release Earnings on Wednesday

Posted by Tristan Rich on Oct 26th, 2026 Shares of MDXG stock opened at $3.91 on Monday. MiMedx Group has a 12 month low of $3.03 and a 12 month high of $7.97. The firm has a market cap of $569.92 million, a PE ratio of 97.77 and a beta of…

From the 4Search news index, newest first.

In the news

12mentions in 30 days
12with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 12 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance